Terry, who this year celebrates 21 years service with Penn, joined the company in 1986 after working in a number of quality and manufacturing posts in the pharmaceutical industry including Geigy and Fisons during which time he worked in West Africa. In addition to having overall responsibility for the company's Quality Group, Terry is also one of Penn’s seven QPs (Qualified Person) and has extensive experience of working with worldwide clients to ensure that importation procedures and EU compliance issues for new drug candidates can and have been addressed. Peter George, CEO of Penn Pharmaceuticals commented: "This well deserved promotion recognises the significant skills Terry has and the contribution he has made to the company over the years and it is a key role that Terry will play in the future development of Penn. "We are a rapidly growing international company and the MBO has presented us with yet another opportunity to drive the business forward. Our enhanced management structure gives us an excellent platform on which to build further growth within the pharmaceutical and biotech industries as we continue to provide market leading services to our clients," he said. Penn is a leading provider of fully integrated and cost effective pharmaceutical development and custom manufacturing services to the international health care industry, whose services support a fast and effective route from drug discovery to market. Penn provides unparalleled service offerings, developed over its 30 year trading history, which are individually excellent and compelling in combination. Penn’s Services include formulation and analytical development, clinical trial manufacturing, packing, storage and supply management, specialised custom manufacturing, CMC consultancy and QP services. Penn has global reach through an international sales force and strategic alliances for its services offered from its single site operation in South Wales. Penn operates quality systems, proven through audit and compliance with GMP. Penn is licensed by MHRA for manufacturing, dealing and import and FDA with whom Penn is registered for certain drug product manufacture and assembly of medical devices. Penn is licensed by the UK Home Office for controlled drugs.